Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7742
Peer-review started: March 25, 2016
First decision: May 12, 2016
Revised: June 30, 2016
Accepted: August 1, 2016
Article in press: August 1, 2016
Published online: September 14, 2016
Processing time: 168 Days and 9.2 Hours
Core tip: Spontaneous bacterial peritonitis (SBP) occurs in patients with end-stage liver disease (ESLD); spontaneous fungal peritonitis (SFP) is a complication of ESLD less known and described. Patients with SFP had a significantly worse prognosis than those with SBP. The incidence accounts from 0% to 13% of patients with ESLD and spontaneous peritonitis. Data are conflicting regarding fungi distribution between nosocomial and non-nosocomial infections. Candida spp. are the most frequent fungal infectious agent isolated. Previous SBP antibiotic prophylaxis, hepatorenal syndrome, low ascitic fluid protein (< 1 g/dL), elevated acute physiology and chronic health evaluation II and serum lactate also significantly adversely impact hospital mortality.
